NOCIL Q1: consolidated PAT surges 61% YoY to ₹27.8 Cr on 20% revenue growth, margins widen
PAT +60.83% YoY · revenue +19.87% · margins expanding
₹403.02 Cr
+19.87% YoY
₹27.76 Cr
+60.83% YoY
6.79%
+1.8pp YoY
₹1.66
NOCIL opened FY27 with a materially stronger print: consolidated revenue rose ~19.9% YoY to ₹403.02 Cr and net profit jumped ~60.8% to ₹27.76 Cr (EPS ₹1.66 vs ₹1.03), comfortably outpacing topline as operating margins expanded. Operating margin (OPM) widened to ~11.2% from ~9.1% a year ago and ~6.4% in the seasonally soft March quarter, driven by operating leverage on higher volumes and contained overheads (other expenses ₹102.66 Cr grew far slower than revenue). The profit growth is fully underlying — neither this quarter nor the year-ago Q1 carried any exceptional item, so the reported and adjusted YoY PAT growth are the same ~61%; the eye-catching +63% QoQ profit is flattered by a weak Q4 FY26 base and is supporting detail, not the headline. Standalone tells the same story (PAT ₹27.32 Cr, +64.8% YoY), with no material divergence from consolidated.
Q1 FY-2027 vs prior quarters
Against management's own guidance from the Q4 concall — double-digit volume growth, Q4 treated as the new base, and ~150 bps EBITDA-margin improvement off FY26 — this quarter runs ahead: revenue is up ~22% on that Q4 base and margin expansion already exceeds the 150 bps target, suggesting the operating-leverage and price-hike thesis is playing through even as the final anti-dumping-duty decision remains pending. No formal Street consensus is on record for a company of this size, so the print cannot be graded against a published estimate. Note the concurrent corporate signals: a promoter pledge of 9 lakh shares (Aug 1) and the 64th AGM held alongside these results (Aug 3); a Q1 concall is scheduled for Aug 4, which should clarify volume trajectory and the margin outlook. No management press release accompanied the numbers.
The stock went into the print at ₹180.81, down 1.7% over the past month of trading.
For context: this is the highest quarterly PAT in the last 6 quarters on our records; PAT has now risen for 2 consecutive quarters; revenue is at a 6-quarter high.
Management guides for a sustained positive momentum with double-digit volume growth in the coming years, viewing Q4 as a new base. They are actively implementing price hikes to counter raw material inflation and target an EBITDA margin improvement of approximately 150 basis points from the FY26 base. This recovery is e
— This quarter: beat
W1
Whether the ~11.2% operating margin holds next quarter vs management's ~150 bps improvement target off the FY26 base
W2
Final anti-dumping-duty decision management flagged as pending — a key demand/pricing catalyst
W3
Sustainability of double-digit volume growth and new-capacity ramp underpinning the ₹403 Cr topline
Clean digitally-generated statement; both basis reconcile (403.02+5.90=408.92; 37.09-9.33=27.76 consol). No exceptional item this quarter or in year-ago Q1 (labour-codes exceptional hit only FY26 full year: ₹5.39 Cr consol/₹4.92 Cr standalone) — YoY comparison is clean, no adjustment needed. Consol adds wholly-owned subsidiary PIL Chemicals (rev ₹4.65 Cr, PAT ₹0.53 Cr); no minority interest.
Informational and educational content only. Not investment advice.